Simran Polce, MD

73 posts

Simran Polce, MD

Simran Polce, MD

@SimranPolce

Rising Radonc @Moffittradonc | Internship @NorthwellHealth | @Stonybrookmed 23' | @NYIT 18'

New York, USA Bergabung Mart 2022
217 Mengikuti137 Pengikut
Simran Polce, MD me-retweet
MoffittRadOnc
MoffittRadOnc@MoffittRadOnc·
Please join us in welcoming our newly matched residents to the @MoffittNews family! Congratulations!!
MoffittRadOnc tweet media
English
2
11
58
3.1K
Simran Polce, MD me-retweet
MoffittRadOnc
MoffittRadOnc@MoffittRadOnc·
Rad Onc residents all dressed up for our breakfast with Moffitt leadership!
MoffittRadOnc tweet media
English
0
7
19
2.5K
Simran Polce, MD
Simran Polce, MD@SimranPolce·
Continuing the conference with a brilliant talk on digital therapeutics in oncology by Dr Hoffe (Interim GI Chair and mentor extraordinaire). @MoffittNews @MoffittRadOnc
Simran Polce, MD tweet mediaSimran Polce, MD tweet mediaSimran Polce, MD tweet media
English
1
2
11
985
Simran Polce, MD me-retweet
MoffittRadOnc
MoffittRadOnc@MoffittRadOnc·
Enjoying some resident bonding while learning about surface guidance and kV triggered imaging at the 2026 @MoffittNews Radiation Oncology Conference! #radonc
MoffittRadOnc tweet mediaMoffittRadOnc tweet mediaMoffittRadOnc tweet media
English
0
4
12
863
Simran Polce, MD me-retweet
ROVERRO
ROVERRO@RadoncROVER·
We are hosting our next virtual case-based teaching session focused on non-traditional brachytherapy, partnering with @ACRORadOnc @AmericanBrachy @GammaTile. Join Drs. Thomas Beckham, Aurelie Garant, and Arash Naghavi on Friday, February 13, 3-4 pm EST! forms.gle/e7J7ktF22tYsPm…
ROVERRO tweet media
English
2
7
14
861
Simran Polce, MD me-retweet
ACRO - American College of Radiation Oncology
We're excited to announce the winners of our #ACRO2026 travel grants supported by the Dr. Luther Brady Foundation and the International Society for Therapeutic Radiology & Oncology (ISTRO)! Congrats to these members on receiving $500 to attend The #RadiationOncology Summit!
ACRO - American College of Radiation Oncology tweet media
English
1
4
13
1.6K
Simran Polce, MD me-retweet
Simran Polce, MD me-retweet
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
At the #ASTRO25 quick pitch session, Simran Polce, MD (@SimranPolce), presented a novel isotoxic hypofractionated adaptive RT approach for locally advanced lung cancer designed for patients ineligible for standard concurrent chemoradiotherapy. Results: 
➡️ Daily adaptive RT boosted target dose by about 8% 
➡️ Reduced esophagus and proximal bronchial tree exposure 
➡️ Well tolerated with no acute grade 3 toxicities 
➡️ Warrants further research and long-term follow-up #MoffittASTRO25
Moffitt Cancer Center tweet mediaMoffitt Cancer Center tweet mediaMoffitt Cancer Center tweet media
English
1
5
11
809
Simran Polce, MD me-retweet
MoffittRadOnc
MoffittRadOnc@MoffittRadOnc·
We had a fantastic time at #ASTRO2025 sharing our work and learning from the leaders in our field. Until next time!
MoffittRadOnc tweet media
San Francisco, CA 🇺🇸 English
2
5
21
2.8K
Simran Polce, MD me-retweet
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
At #ASTRO25, Simran Polce, MD (@SimranPolce), shared results on quality of life and SBRT in patients with interstitial lung disease (ILD) and non-small cell lung cancer (NSCLC). Key findings: 
• Among 30 ILD patients with NSCLC, SBRT was generally well tolerated, with one treatment-related fatality and eight additional non-ILD/non-treatment deaths.
• Respiratory adverse events occurred in eight patients; every-other-day regimens were linked to fewer events, while steroid use and proposed dose limits showed no correlation.
• Findings suggest every-other-day SBRT may improve quality of life, though further prospective studies are needed to refine treatment strategies for ILD patients. #MoffittASTRO25
English
0
4
10
864
Simran Polce, MD me-retweet
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
At the #ASTRO25 poster session, Simran Polce, MD (@SimranPolce), shared new data showing radiotherapy can quickly control bleeding in hospitalized patients, improving quality of life and potentially shortening hospital stays. In a study of 126 inpatient consults, RT was feasible in most cases and achieved hemostasis in about 65% of patients. Many required alternative care, pointing to the need for improved consultation and treatment processes. #MoffittASTRO25
English
1
5
16
2.4K
Simran Polce, MD me-retweet
Moffitt Cancer Center
Moffitt Cancer Center@MoffittNews·
Live from #ASTRO25 in San Francisco: Kosj Yamoah, MD, PhD (@KOSJ12) chats with Simran Polce, MD (@SimranPolce), winner of quick pitch abstract award in cancer biology, on adaptive radiotherapy for lung cancer — safely escalating dose while reducing toxicity.
English
2
7
17
842
Simran Polce, MD
Simran Polce, MD@SimranPolce·
Check out Dr Washington’s discussion on PMRT consensus updates at #ASTRO25 She’s also a co author on the full PMRT ASTRO-ASCO-SSO guideline updates just published ascopubs.org/doi/10.1200/JC…. FYI for prospective applicants she’s one of our core teaching faculty members.
Simran Polce, MD tweet mediaSimran Polce, MD tweet media
English
0
4
14
945